Global Graphics SE: Trading Update For The Quarter Ended 31

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
76
Global Graphics SE: Trading Update For The Quarter Ended 31 March 2017

PRESS RELEASE - REGULATED INFORMATION

GLOBAL GRAPHICS SE: TRADING UPDATE FOR THE QUARTER ENDED 31 MARCH 2017

Cambridge (UK) Tuesday 11 April 2017 (18.00 CEST) - GLOBAL GRAPHICS SE (Euronext: GLOG) provides a trading update for the first quarter of the financial year ending 31 December 2017.

Gary Fry, CEO reports "we have had an extremely strong quarter bearing in mind that there was no exceptional item as there was this time last year. A considerable amount of growth has been due to the acquisition of Meteor Inkjet Limited ("Meteor").  We are extremely pleased with how the integration of Meteor has progressed and with their excellent team. We are also very pleased with the joint opportunities that have already emerged and with the extra value we have been able to generate for our existing joint customers. The inkjet sector is extremely vibrant and represents a strong opportunity for Global Graphics due to our ability to add significant value for manufacturers in terms of software, fonts and drive electronics, individually or as a complete solution."

Financial highlights for the quarter ended 31 March 2017

The following information is unaudited.

  • Revenue for the quarter was €4.70 million (2016: €5.25 million)
  • Gross profit for the quarter was €3.61 million, or 77% of sales (2016: €4.94 million, 94% of sales)
  • EBITDA for the quarter was €0.73 million (2016: €2.34 million)
  • Cash at 31 March 2017 was valued at €4.30 million (2016: €3.41 million)

Segment sales analysis The following table provides information about revenue for the Group's operating segments for the quarter ended 31 March 2017.

  Quarter ended 31 March
€ millions 2017 2016
Print 3.88 4.50
eDoc 0.11 0.17
Fonts 0.71 0.58
Total revenue 4.70 5.25

During the quarter ended 31 March 2016, a customer in the Print segment exercised a multi-year option in their contract which resulted in the recognition of revenue totalling €2.87 million during that quarter.  There was no such item in the quarter ended 31 March 2017.

Gross profit Following the acquisition of Meteor in December 2016, the Group's sales are now comprised of software and a significant proportion of hardware.  The hardware revenue attracts a higher cost of sale, resulting in lower gross margins, so gross profit margins will be influenced by the mix of product that is sold during the period.

EBITDA Historically, the Group has reported its own measure of adjusted operating profit in addition to the IFRS reported profit, however, to be consistent with general practice and to use a more familiar measure, it will report EBITDA as an alternative measure of profit.

EBITDA is calculated by adding back interest, tax, depreciation and amortisation to net profit.

For reference, EBITDA for the preceding three financial years was:

  Year ended 31 December
€ millions 2016 2015 2014
EBITDA 4.29 5.00 3.72

Cash The Group continues to be free of any interest bearing debt, therefore, has no interest payments or capital repayments to make.

The terms of the acquisition of Meteor necessitates a deferred consideration payment, payable in cash, which is contingent on revenue.  The first payment was made during the quarter ended 31 March 2017.

Annual General Meeting

As announced earlier today, the Company's Annual General Meeting will be held at the offices of Andlinger & Co, Avenue Louise 326, 1050 Brussels, Belgium on Monday 8 May 2017 at 14:00 hrs (CEST).

A copy of the complete notice and other supporting information, including explanatory notes, requirements for proof of ownership of shares and the proxy form, is available for download from the investors section of the Company's web site at: http://www.globalgraphics.com/investors/share...al-meeting .

Results for the six months ending 30 June 2017

The Company expects to publish its condensed consolidated financial statements for the six months ending 30 June 2017 after market close on Wednesday 26 July 2017.

 

About Global Graphics

Global Graphics SE (Euronext: GLOG)  http://www.globalgraphics.com  is a leading developer of platforms for digital printing, including the Harlequin RIP®. Customers include  HP, Canon, Delphax, Roland,  Kodak and Agfa .  The roots of the company go back to 1986  and to the iconic university town of Cambridge, and, today the majority of the R&D team is still based near here. The font foundry, URW++ Design and Development GmbH, and the industrial printhead driver solutions specialists, Meteor Inkjet, are subsidiary companies of Global Graphics SE.  Global Graphics has offices in: Boston, US; Tokyo, Japan; and Hamburg, Germany.

Contacts

Graeme Huttley Jill Taylor
Chief Financial Officer Corporate Communications Director
Tel: +44 (0)1223 926472 Tel: +44 (0)1223 926489
Email: graeme.huttley@globalgraphics.com Email: jill.taylor@globalgraphics.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading